Abstract:Abstract Background Somatic cells differentiated from patient-specific human induced pluripotent stem cells (iPSCs) could be a useful tool in human cell-based disease research. Hermansky–Pudlak syndrome (HPS) is an autosomal recessive genetic disorder characterized by oculocutaneous albinism and a platelet dysfunction. HPS patients often suffer from lethal HPS associated interstitial pneumonia (HPSIP). Lung transplantation has been the only treatment for HPSIP. Lysosome-related organelles are impaired in HPS, thereby disrupting alveolar type 2 (AT2) cells with lamellar bodies. HPSIP lungs are characterized by enlarged lamellar bodies. Despite species differences between human and mouse in HPSIP, most studies have been conducted in mice since culturing human AT2 cells is difficult. Methods We generated patient-specific iPSCs from patient-derived fibroblasts with the most common bi-allelic variant, c.1472_1487dup16, in HPS1 for modeling severe phenotypes of HPSIP. We then corrected the variant of patient-specific iPSCs using CRISPR-based microhomology-mediated end joining to obtain isogenic controls. The iPSCs were then differentiated into lung epithelial cells using two different lung organoid models, lung bud organoids (LBOs) and alveolar organoids (AOs), and explored the phenotypes contributing to the pathogenesis of HPSIP using transcriptomic and proteomic analyses. Results The LBOs derived from patient-specific iPSCs successfully recapitulated the abnormalities in morphology and size. Proteomic analysis of AOs involving iPSC-derived AT2 cells and primary lung fibroblasts revealed mitochondrial dysfunction in HPS1 patient-specific alveolar epithelial cells. Further, giant lamellar bodies were recapitulated in patient-specific AT2 cells. Conclusions The HPS1 patient-specific iPSCs and their gene-corrected counterparts generated in this study could be a new research tool for understanding the pathogenesis of HPSIP caused by HPS1 deficiency in humans.

Generation of a healthy heavy smoker patient-derived induced pluripotent stem cell line UHOMi007-A from peripheral blood mononuclear cells

Inducing Pluripotency for Disease Modeling, Drug Development and Craniofacial Applications.

A Comparison of Murine Smooth Muscle Cells Generated from Embryonic Versus Induced Pluripotent Stem Cells

Generation of a Human Induced Pluripotent Stem Cell Line (Shupli001-A) from PBMCs of a Healthy Male Donor.

Generation of a Human Induced Pluripotent Stem Cell Line (Shupli002-A) from PBMCs of a Healthy Female Donor

Directed differentiation of mouse pluripotent stem cells into functional lung-specific mesenchyme

Generation of Complete Multi−Cell Type Lung Organoids From Human Embryonic and Patient‐Specific Induced Pluripotent Stem Cells for Infectious Disease Modeling and Therapeutics Validation

Generation and characterisation of a human induced pluripotent stem cell line, NIMHi007-A, from peripheral blood mononuclear cells derived from an adult healthy female

Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells

Modeling of lung phenotype of Hermansky–Pudlak syndrome type I using patient-specific iPSCs

Generation of a Human Induced Pluripotent Stem Cell Line from a 65-Year Old Healthy Female Donor with Chinese Han Genetic Background

Generation of a Human Control PBMC Derived Ips Cell Line TUSMi001-A from a Healthy Male Donor of Han Chinese Genetic Background

Induced Pluripotent Stem Cell Line (Zzuneui011-A) Derived from Peripheral Blood Mononuclear Cells (pbmcs) of a Healthy 27-Year-old Female Individual.

Generation and Characterization of Ipsc Lines (BCH001) from a Boy with Intron 14 Mutation in the Ret Proto-Oncogene (RET) Gene.

Generation of a Human Induced Pluripotent Stem Cell Line from a Female Patient Carrying LZTR1 Gene Mutation

Human induced pluripotent stem cell line from fibroblasts (HEBHMUi015-A) and chondrogenic differentiation

Generation of an induced pluripotent stem cell line SDPHi002-A from a patient with lung cancer

Modélisation de l'asthme sévère par la technologie des cellules humaines souches pluripotentes induites (hiPSC)

Application of iPSC to Modelling of Respiratory Diseases

Efficient generation of induced pluripotent stem cell lines from healthy donors' peripheral blood mononuclear cells from different genders

Development of a bronchial epithelium model innervated by sensory neurons from human induced pluripotent stem cells